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DOI 10.1016/j.cmet.2010.06.010SUMMARY cause of infertility in women. In addition to obesity and hyper-Obesity is associated with insulin resistance in meta-
bolic tissues such as adipose, liver, and muscle, but
it is unclear whether nonclassical target tissues,
such as those of the reproductive axis, are also
insulin resistant. To determine if the reproductive
axis maintains insulin sensitivity in obesity in vivo,
murine models of diet-induced obesity (DIO) with
and without intact insulin signaling in pituitary gona-
dotrophs were created. Diet-induced obese wild-
type female mice (WT DIO) were infertile and experi-
enced a robust increase in luteinizing hormone (LH)
after gonadotropin-releasing hormone (GnRH) or
insulin stimulation. By contrast, both lean and obese
mice with a pituitary-specific knockout of the insulin
receptor (PitIRKO) exhibited reproductive compe-
tency, indicating that insulin signaling in the pituitary
is required for the reproductive impairment seen in
DIO and that the gonadotroph maintains insulin
sensitivity in a setting of peripheral insulin resis-
tance.
INTRODUCTION
Nutritional status is tightly coupled to reproductive function.
Short-term and chronic withdrawal of nutrients is known to
inhibit reproductive function in mammals (Cameron and Nos-
bisch, 1991), likely an evolutionary adaptation to the large
amount of energy required for reproduction. In addition, condi-
tions of excess nutrition, such as obesity, have also been linked
to reproductive dysfunction. Infertility is associated with condi-
tions such as type 2 diabetes, metabolic syndrome, and poly-
cystic ovarian syndrome (PCOS). These conditions are marked
by obesity and a complex metabolic phenotype that includes
hyperinsulinemia and hyperleptinemia as well as insulin and
leptin resistance. Of these metabolic disorders linked to infer-
tility, PCOS is the best characterized and is the most commonCell Meinsulinemia, PCOS is associated with anovulation and elevated
luteinizing hormone (LH) levels, suggesting that the central
reproductive axis is tonically activated, leading to ovarian
dysfunction.
We and others have shown that insulin and insulin-like growth
factors can augment the effects of gonadotropin-releasing
hormone (GnRH) on LH expression and secretion (Adashi
et al., 1981; Buggs et al., 2006; Soldani et al., 1995) in vitro using
LH-secreting gonadotroph cell lines, suggesting that direct
insulin action in the gonadotroph may contribute to the elevated
LH observed in women with PCOS. In contrast to studies
showing that insulin can augment GnRH (Buggs et al., 2006),
GnRH has also been shown to inhibit an insulin response
in vitro (Navratil et al., 2009). Some groups have noted that in
PCOS women, insulin injection caused circulating gonadotropin
levels to decrease (Lawson et al., 2008; Mehta et al., 2005; Patel
et al., 2003). This suggests that the dysregulation of LH synthesis
and/or release in PCOS may be due to insulin dysregulation at
the level of the gonadotroph; however, whether the central
reproductive tissues maintain insulin sensitivity in the presence
of hyperinsulinemia and peripheral insulin resistance remains
unclear. While women with PCOS and infertility display insulin
resistance in insulin target tissues such as liver and muscle, it
is unknown whether the central reproductive axis is also insulin
resistant. Approaching this question has been hampered by
the difficulty in generating a rodent model to mimic the complex
phenotype of PCOS.Mixed results have stemmed from attempts
to model the obese, infertile state, and somemouse strains have
reacted differently to the effects of a high-fat diet (HFD) (Tortor-
iello et al., 2004). Consequently, a clear view of nutritional regu-
lation of the reproductive axis has yet to be defined.
Given the discrepant in vitro observations of the gonadotroph
response to insulin, we chose to focus on isolating the role of
insulin in vivo in the reproductive axis as an important signaling
factor of overnutrition. To determine the direct effects of insulin
on the gonadotroph, our laboratory has developed a pituitary-
specific insulin receptor (IR) knockout (KO), or PitIRKO, mouse.
In this study, we use the PitIRKO model to directly assess the
role of insulin signaling in the pituitary gonadotroph in the
context of infertility associated with diet-induced obesity (DIO).tabolism 12, 295–305, September 8, 2010 ª2010 Elsevier Inc. 295
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Figure 1. Development of PitIRKO Mouse
(A) Mouse insulin receptor (IR) gene. Mice bearing loxP
sites flanking exon 4 of the IR were crossed with mice
carrying common a subunit-driven Cre recombinase to
generate pituitary-specific knockdown of the IR, or
PitIRKO. Primers P1 and P2 were designed to indicate
the presence of the loxP site 30 of exon 4. Primer P3 and
P2 produce a band following Cre recombination.
(B) PCR products from reactions performed on genomic
DNA from a variety of tissues indicate the presence of
homozygous floxed alleles (320 bp) in all tissues and the
knockout (KO) product following Cre recombination in
the pituitary (220 bp).
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Generation of PitIRKO Mice
PitIRKO mice were generated by breeding homozygous floxed
IR mice (Bru¨ning et al., 2000) with mice expressing Cre recombi-
nase under the control of the promoter of the a subunit of gonad-
otropins (aGSU) to target the anterior pituitary (Naik et al., 2006).
Our model (Singh et al., 2009) and others targeting the same cell
types (Savage et al., 2007) have been shown to specifically
target gonadotrophs. PitIRKOmice were born with the expected
Mendelian frequency and were of normal size and weight. Mice
were genotyped using a PCR strategy schematized in Figure 1.
Upon expression of the Cre recombinase enzyme, exon 4 of
the IR is excised, resulting in loss of function of the IR. The
PCR product indicating the homozygous floxed IR alleles
(320 bp) were present in all tissues, while a KO-specific band
(220 bp) was present only in the pituitary (Figure 1B). The prod-
ucts produced in the pituitary indicate both the presence of the
floxed alleles and the KO-specific band as a result of the mixed
cell population.Lean PitIRKO Females Have Normal Reproductive
Function
Reproductive function of lean PitIRKO females was assessed via
evaluating estrous cyclicity and breeding studies. Ten lean
PitIRKO females were analyzed for vaginal cytology over the
course of 10 days, and each displayed a regular pattern of
cycling, passing through each stage of the estrous cycle and
only remaining in any one stage for 1–2 days, as represented
by the plot in Figure 2A. Mating of PitIRKO lean females with
WT proven fertile males showed no differences in breeding
success rate, number of pups per litter, or length of gestation
compared to littermate controls (Figures 2B–2D).296 Cell Metabolism 12, 295–305, September 8, 2010 ª2010 Elsevier Inc.DIO Mice Display Hallmarks of Insulin
Resistance
At 8 weeks of age, WT and PitIRKO mice were
placed on a HFD (60% kcal from fat) and main-
tained on the diet for 12 weeks prior to evalua-
tion. DIO mice were evaluated for weight gain
over the course of the 12 week period, and fast-
ing glucose, insulin, and leptin levels were then
determined. Mice fed a regular chow diet hada range of weight gain between 10 and 15 g while DIO mice
gained between 17 and 23 g over the 12 week period
(Figure 3A). Both WT and PitIRKO DIO mice displayed signifi-
cantly higher fasting blood glucose, insulin levels, and leptin
levels than lean mice, indicating that loss of the IR in the
gonadotroph does not affect peripheral glucose metabolism
(Figures 3B–3D).
The Gonadotroph IR Regulates LH Secretion from the
Pituitary on an Obese, Hyperinsulinemic Background
Baseline serum LH levels were nearly doubled in WT DIO mice
compared to WT lean controls (Figure 4A). Although serum
follicle-stimulating hormone (FSH) levels were elevated by
nearly 40% in WT DIO mice compared to WT lean mice, this
difference did not achieve statistical significance (Figure 4B).
While there was no significant difference in baseline LH levels
in the presence or absence of IR in the gonadotroph in the
chow-fed female mice, serum LH levels were lower in the
PitIRKO DIO than in WT DIO mice (Figure 4A). The LH levels
in the PitIRKO DIO mice were not different from baseline levels
observed in chow-fed female mice. To determine whether
differences in gene expression contributed to the differences
in observed LH levels, quantitative PCR was performed on
pituitaries collected from each group. Relative aGSU and the
LH-b subunit mRNA was assessed, and both showed increased
basal levels in the WT DIO mice (Figures 4C and 4D). Both
PitIRKO lean and PitIRKO DIO females had serum LH and
mRNA levels similar to the WT lean group and significantly lower
levels than WT DIO. We also observed a statistically significant
(p < 0.05) increase in serum testosterone in WT DIO females
(19.3 ng/dl, n = 25) relative to lean WT females (10.4 ng/dl,
n = 12), suggesting that DIO in our strain of mice is a suitable
model of PCOS.
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Figure 2. Reproductive Assessment of Lean PitIRKO Female Mice
(A) Representative vaginal cytology plot from a lean PitIRKO female mouse. Eight PitIRKO females were analyzed, and each showed a regular cycling pattern.
(B) Mating success rate of WT lean and PitIRKO lean females.
(C) Gestation periods.
(D) Litter sizes. WT lean, n = 13; PitIRKO lean, n = 10. Data are represented as mean ±SEM.
Cell Metabolism
PitIRKO Rescues DIO-Associated InfertilityWT DIO Mice Are More Responsive to GnRH Stimulation
Than WT Lean Mice due to Upregulation of the GnRH
Receptor
Previous studies have indicated that insulin augments GnRH
stimulation of LHb gene expression and LH secretion (Buggs
et al., 2006; Xia et al., 2001). To explore the effect of obesity
and hyperinsulinemia on GnRH-induced LH release from the
pituitary, a GnRH stimulation test was performed. WT and
PitIRKO lean mice both experienced an 8-fold increase in LH
after GnRH stimulation, while WT DIO mice had an approxi-
mately 16-fold increase (Figure 4E). In contrast to WT DIO mice
showing an increased response to GnRH stimulation, PitIRKO
DIO mice had a significantly reduced GnRH response, with only
a 3-fold increase in serum LH following GnRH stimulation. To
investigate a potential mechanism for the increased sensitivity
to GnRH in the WT DIO mice, relative baseline GnRH receptor
(GnRH-R) mRNA levels were compared across groups. Baseline
GnRH-R mRNA levels were more than 14-fold higher in WT DIO
versus other groups (Figure 4F). GAPDH was used as a control
and was not significantly different among groups (Figure 4G).
WT DIO Female Mice Display Irregular Estrous Cyclicity
and Develop Fewer Corpora Lutea while Cyclicity and
Corpora Lutea Are Retained in PitIRKO DIO Mice
Estrous cyclicity was examined to evaluate ability to generate an
LH surge and induce ovulation. WT and PitIRKO lean femalesCell Mecycled regularly, while WT DIO animals remained in the diestrus
phase of the estrous cycle (Figure 5A). Interestingly, PitIRKODIO
females retained their cyclicity, showing a regular cycling pattern
comparable to theWT lean and PitIRKO lean females (Figure 5A).
WT DIO mice spent a significantly higher percentage of time in
the diestrus phase than lean controls and PitIRKO DIO mice
and a significantly lower percentage of time in the proestrus,
estrus, and metestrus phases (Figure 5B). PitIRKO DIO mice fol-
lowed a pattern similar to WT and PitIRKO lean females.
Corpora lutea were quantified as a marker of recent ovulation.
Histological sections of ovaries revealed a similar number of
corpora lutea in WT lean and PitIRKO lean, with PitIRKO DIO
mice showing an intermediate number of corpora lutea. Signifi-
cantly fewer corpora lutea were found in WT DIO mice (Figures
5C and 5D), consistent with the persistent state of diestrus found
in the WT DIO females.
Removal of Gonadotroph IR Protects against Infertility
in DIO
Female mice were housed for 7 days with proven fertile males,
and four cycles of pairings were evaluated. Themales were alter-
nated between pairings with DIO and chow-fed females in order
to minimize any effects of diet on male reproductive function.
Figure 6A shows a chart of successful mating events for five
representative females for each group. The data for all mice
are summarized in Figure 6B and demonstrate that WT leantabolism 12, 295–305, September 8, 2010 ª2010 Elsevier Inc. 297
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Figure 3. DIO Model
(A) Total body weight of WT lean, PitIRKO lean, WT DIO, and PitIRKO DIO mice over the course of 12 weeks.
(B–D) Fasting blood glucose levels (B), fasting serum insulin levels (C), and fasting serum leptin levels (D) across groups. WT lean, n = 12; PitIRKO lean, n = 8;
WT DIO, n = 25; PitIRKO DIO, n = 10. Data are represented as mean ±SEM. Asterisks indicate a significant difference between lean and DIO: *p value less
than 0.05, **p value less than 0.01.
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PitIRKO Rescues DIO-Associated Infertilityand PitIRKO lean females exhibited fertility rates six times higher
thanWT DIOmice. As with numbers of corpora lutea (Figure 5D),
PitIRKO DIO females had significantly improved fertility rates
relative to WT DIO females (Figure 6B). For the litters that were
born, the numbers of pups per litter and gestation periods
were the same across groups (data not shown).
Insulin Stimulates an Increase in Circulating LH Levels
To explore the acute response of the pituitary to insulin, circu-
lating LH levels were measured before and after a peripheral
injection of insulin. Forty minutes after insulin administration,
serum LH levels increased by 58% in chow-fed mice and by
46.5% in WT DIO mice. Insulin administration did not increase
LH levels in PitIRKO animals (Figure 7A).
The Pituitary Remains Insulin Sensitive under Infertile,
DIO Conditions
Pituitary insulin responsiveness was assessed via insulin
signaling assay. Mice were treated with insulin or saline after
overnight fasting and harvested for liver, muscle, and pituitary
tissue samples. Following insulin treatment, p-Akt levels
increased in liver and muscle as well as in pituitary tissue in
WT lean mice (Figure 7B). WT DIO mice exhibited blunted phos-
phorylation of Akt in liver and muscle after insulin administration,298 Cell Metabolism 12, 295–305, September 8, 2010 ª2010 Elsevieindicating peripheral insulin resistance. The WT DIO pituitary
showed a significantly increased basal p-Akt level compared
to WT lean, indicating preserved insulin sensitivity in the WT
DIO pituitary to elevated insulin levels observed under basal
conditions (Figure 7B). This sensitivity was lost in the PitIRKO
DIO mice, reflecting the lack of IR in the aGSU-expressing cells.
After insulin administration, pituitary p-Akt levels were further
increased in WT DIO mice, but no effect of insulin was observed
in PitIRKO DIO mice. PitIRKO DIO liver and muscle displayed
signaling profiles similar to WT DIO, indicative of peripheral
insulin resistance.DISCUSSION
The current rise in obesity and associated disorders such as type
2 diabetes, metabolic syndrome, and PCOS has drawn attention
to the effect of these diseases on the reproductive system.
Conditions marked by hyperinsulinemia are associated with
infertility and abnormal regulation of LH secretion, yet the under-
lying mechanisms for these derangements remain unknown. To
determine if insulin signaling at the pituitary gonadotroph plays
a role in infertility related to obesity, we developed mice with
the IR specifically deleted in the pituitary gonadotroph using
the CRE/lox system. PitIRKO female mice on a regular chowr Inc.
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Figure 4. Basal Gonadotropin Levels Are Elevated in WT DIO Mice, and WT DIO Mice Are the Most Responsive to GnRH Stimulation
(A) Baseline serum luteinizing hormone (LH) levels across groups. Assay detection limit = 0.048 ng/ml.
(B) Baseline follicle stimulating hormone (FSH) levels across groups. Assay detection limit = 0.032 ng/ml. WT lean, n = 12; PitIRKO lean, n = 10; WT DIO, n = 24;
PitIRKO DIO, n = 10.
(C and D) Basal relative aGSU (C) and LH-b mRNA levels (D) across groups.
(E) Fold change in serum LH following injection of GnRH.
(F) Basal relative GnRH receptor mRNA levels.
(G) GAPDH was also measured as an unregulated control. WT lean, n = 11–16; PitIRKO lean, n = 7–8; WT DIO, n = 12–19; PitIRKO DIO, n = 8–10. Data are rep-
resented as mean ±SEM.
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Figure 5. PitIRKO Rescues Estrous Cyclicity and Ovulation on DIO Background
(A) Representative vaginal cytology plots from lean and DIO WT and PitIRKO mice.
(B) Percent time spent in each stage of the estrous cycle by WT lean, WT DIO, and PitIRKO DIO animals. WT lean, n = 9; WT DIO, n = 25; PitIRKO DIO, n = 8.
(C) Representative histological sections of ovaries taken from WT lean, WT DIO, and PitIRKO DIO mice. * = corpora lutea.
(D) Total corpora lutea (CL) counts from each group.WT lean, n = 13; PitIRKO lean, n = 4;WTDIO, n = 11; PitIRKODIO, n = 7. Data are represented asmean ±SEM.
Asterisks indicate a significant difference between WT DIO and WT lean/PitIRKO DIO: **p value less than 0.01, ***p value less than 0.001.
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PitIRKO Rescues DIO-Associated Infertilitydiet displayed normal reproductive function, but in a model of
DIO, PitIRKOmice retained fertility while WT mice became infer-
tile. This suggests that IR signaling in the pituitary is fundamental
to the dysregulation of LH secretion associated with the obese
state.
Evidence has pointed to both increased GnRH pulsatility and
increased pituitary sensitivity to GnRH as a cause for the inap-300 Cell Metabolism 12, 295–305, September 8, 2010 ª2010 Elseviepropriate gonadotropin secretion associated with PCOS (Hall
et al., 1998), yet the mechanism underlying the increased pitui-
tary sensitivity to GnRH in PCOS has not been fully elucidated.
Some studies have shown that insulin enhances LH secretion
and expression in vitro by augmenting GnRH action (Buggs
et al., 2006; Soldani et al., 1994; Xia et al., 2001), implicating hy-
perinsulinemia and intensified gonadotropic insulin signaling asr Inc.
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Figure 6. PitIRKO Rescues Infertility Associated with DIO
(A) Representative breeding study illustration: female mice were paired with
four WT males for 7 days and then returned to their own cages for 3 weeks
to allow for birth of pups, indicating a successful pairing. Each row represents
one individual female, and each bar represents one of her pairings. Five exam-
ples were chosen from each group in order to illustrate the fertility phenotypes.
(B) Mating success rate for WT and PitIRKO groups under lean and DIO condi-
tions. WT lean, n = 14; PitIRKO lean, n = 7; WT DIO, n = 13; PitIRKO DIO, n = 7.
Data are represented as mean ±SEM.
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PitIRKO Rescues DIO-Associated Infertilitya cause for the increased LH levels observed in PCOS. Other
studies performed in normal and obese PCOS women indicate
that prolonged insulin infusion neither alters LH secretion (Patel
et al., 2003) nor gonadotropin responses to GnRH (Mehta
et al., 2005). It may be noted, however, that these studies involve
isolated infusions of high concentrations of insulin, and these
short-term supraphysiologic increases in insulin may regulateCell Methe reproductive axis differently than chronically elevated levels
observed in states of insulin resistance.
In nonobese conditions, evidence for nutritional input to the
reproductive axis has been well documented, but a specific
role for insulin signaling in the pituitary has yet to be described.
PitIRKO was used to investigate the role of insulin signaling in
the pituitary gonadotroph. When fed a standard low-fat diet,
WT mice and PitIRKO mice exhibited similar fertility rates,
estrous cyclicity, LH and FSH levels, and corpora lutea counts,
demonstrating that IR signaling in the pituitary is not required
for normal reproductive function. While it is possible that
insulin-like growth factor (IGF-1) signaling may compensate for
the IR impairment, the binding affinity of insulin for the IGF-1R
is relatively low, and the receptor is unlikely to be activated
even at the elevated levels in obesity (Froesch and Zapf, 1985;
Simpson et al., 1998). However, both IGF-1R and IR signal
through the insulin receptor substrate (IRS) proteins (Kim and
Accili, 2002; Nakae et al., 2001), and IRS-2 KO mice are infertile
with decreased serum LH levels (Burks et al., 2000), indicating
that this common signaling pathway plays a role in regulating
fertility under normal chow-fed conditions.
Having determined that lean WT and PitIRKO mice do not
differ in the reproductive parameters assessed, mice were
made obese to investigate the role of insulin signaling in the pitu-
itary under hyperinsulinemic conditions. After 3 months on
a HFD, WT DIO mice displayed the hallmarks of insulin resis-
tance, including fasting hyperglycemia, hyperinsulinemia, and
hyperleptinemia, consistent with the metabolic pattern seen in
other mouse models of DIO (Batt and Mialhe, 1966; Kleinridders
et al., 2009; Lin et al., 2000; Taketomi et al., 1973; Tortoriello
et al., 2004). WT DIO mice showed abnormal estrous cyclicity
patterns (Figures 5A and 5B) and fewer ovulations (Figures 5C
and 5D) mirrored by impaired breeding capacity (Figure 6),
similar to PCOS women. The elevated baseline LH levels seen
in the DIO model (Figure 4) are also similar to results in PCOS
women, where increased GnRH pulsatility and chronically
elevated serum LH levels have been observed (Hall et al.,
1998; Lawson et al., 2008; Marshall and Eagleson, 1999; Rebar
et al., 1976). WT DIO mice remained in persistent diestrus and
showed elevated LH serum and mRNA levels, which may be
due to increased GnRH responsiveness of the pituitary gonado-
troph (Figure 4E). The elevated LH levels may be the primary
mediator of the infertility associated with the diet-induced obese
state, as infertility in female mice with elevated levels of LH has
previously been reported (Singh et al., 2009).
WT DIOmice also showed increased sensitivity to GnRH stim-
ulation, similar to the increased LH responsiveness to GnRH that
has been shown in PCOS women (Patel et al., 2003). The
absence of increased sensitivity to GnRH in PitIRKO DIO mice
implies a role for the IR in contributing to the increase in GnRH
sensitivity.We propose that the pituitary remains insulin sensitive
to chronically elevated insulin levels found in the DIO model and
modifies the pituitary response to GnRH, in accordance with
in vitro data showing insulin augmentation of GnRH in gonado-
trophs (Adashi et al., 1981; Buggs et al., 2006; Soldani et al.,
1995).
aGSU and LH-b mRNA levels were highest in WT DIO mice,
suggesting that elevated serum LH levels may be mediated by
changes in transcriptional regulation of the LH subunit genes.tabolism 12, 295–305, September 8, 2010 ª2010 Elsevier Inc. 301
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Figure 7. Preserved Insulin Sensitivity in WT DIO Pituitary
(A) Serum LH levels before and after mice were injected with insulin. WT
lean, n = 10; PitIRKO lean, n = 12; WT DIO, n = 7; PitIRKO DIO, n = 11.
(B) Signaling assay showing baseline and insulin-stimulated p-Akt in the
pituitary, liver, and muscle. AU = Arbitrary Units. Three to five animals
were used in each group. Data are represented as mean ±SEM.
Cell Metabolism
PitIRKO Rescues DIO-Associated InfertilityReduced LH subunit mRNA levels in the PitIRKO DIO mice
compared to WT DIO mice implicate insulin signaling in this
process, as previously observed in vitro (Buggs et al., 2006).302 Cell Metabolism 12, 295–305, September 8, 2010 ª2010 Elseviein
fo
(LGnRH-R mRNA levels were increased in WT DIO compared
to WT lean and PitIRKO DIO (Figure 4F). These data suggest
that insulin may modulate GnRH-R levels to cause the
increased LH secretion after GnRH stimulation found in DIO
mice (Figure 4E). Whether the increase in LH subunit expres-
sion observed in the DIO mice is due primarily to the
increased GnRH-R or whether insulin can directly regulate
LH subunit expression cannot be clarified by these studies,
but in vitro data suggest that insulin treatment alone cannot
regulate LHb expression (Buggs et al., 2006). Further investi-
gation will elucidate the mechanism by which insulin regu-
lates GnRH-R expression.
Obesity is known to produce insulin resistance in the
classic target tissues of insulin action, such as the liver and
muscle (Biddinger and Kahn, 2006; Kitamura and Accili,
2004). However, whether the reproductive axis remains
insulin sensitive in the setting of peripheral insulin resistance
is controversial. To test the responsiveness of the pituitary to
insulin stimulation in the absence or presence of obesity or in
the absence or presence of the pituitary IR, mice were in-
jected with insulin and acute LH responses were measured.
WT lean mice showed an increase in serum LH following
insulin injection, while PitIRKO mice, lacking the IR, did not
show a response, indicating a direct role for insulin signaling
in regulating LH secretion. WT DIO mice had higher baseline
serum LH levels but still showed an increase in insulin-stimu-
lated LH levels, suggesting that the pituitary gonadotroph is
still sensitive in the obese state. Phospho-Akt, an intracellular
marker of insulin action, was increased at baseline in the
pituitaries of WT DIO mice prior to insulin treatment. After
insulin treatment, the liver and muscle of DIO mice exhibited
insulin resistance, as expected, with reduced activation of
p-Akt compared to the response in the lean mice. The DIO
pituitary exhibited higher basal p-Akt compared to lean
mice, likely reflecting the hyperinsulinemia of the DIO mice.
After insulin stimulation, Akt phosphorylation in the pituitary
increased to a similar level in lean and DIO mice, in contrast
to the effect of insulin on Akt phosphorylation in the liver
and muscle, which did not reach the same level in DIO
mice compared to lean mice after insulin administration.
This indicates enduring insulin sensitivity in the pituitary on
the hyperinsulinemic background. The preserved insulin
sensitivity seen in theWTDIO pituitary was lost in the PitIRKO
DIO. In this model, IR KO is targeted to aGSU-expressing
cells in the pituitary but does not target every cell type.
PitIRKO DIO mice did not exhibit significantly increased
phospho-Akt in response to insulin, suggesting either that
the other cell types in the pituitary do not express IR or that
sulin signaling in other cell types does not activate Akt. A role
r insulin regulation of the somatotroph has been proposed
uque and Kineman, 2006; Melmed et al., 1985), but the Aktr Inc.
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the effect of insulin is found to be inhibitory in the growth
hormone axis, this may explain why p-Akt levels were not
activated in other cell types.
Tissue-specific differences in insulin sensitivity could bemedi-
ated at the level of the receptor, but a more likely locus would be
tissue-specific differences in IRS-1 or -2 serine/threonine phos-
phorylation or proteasomal degradation (reviewed by White,
2006), as these are thought to underlie insulin resistance in
peripheral tissues. Alternatively, the pituitary may not be sensi-
tive to mechanisms causing insulin resistance in peripheral
tissues. Perhaps the evolutionary history of insulin sensitivity in
the reproductive axis has diverged from that in the metabolic
tissues.
While fertility improved by deletion of the IR in the pituitary of
DIO mice, it was not restored to normal. These data suggest
that insulin signaling or perhaps another nutritional signal may
act at another level in the reproductive axis to cause infertility
associated with obesity. Dysregulation at the level of the ovary
is suggested by the incomplete rescue of fertility and corpora
lutea numbers in the PitIRKO DIO mice when compared to WT
or PitIRKO lean mice, despite serum LH levels and pituitary
GnRH sensitivity that are indistinguishable in PitIRKO DIO mice
when compared to WT or PitIRKO lean mice.
Insulin sensitivity in the ovary has been implicated in studies in
which the ovary specifically responds to insulin (Poretsky and
Kalin, 1987). In addition, insulin treatment of rat ovaries has
been found to decrease follicle development in a time-depen-
dent manner (Ozbilgin and Kuscu, 2005). Others have found
that the ovary becomes insulin resistant in PCOS patients (Wu
et al., 2003). In addition to obesity, polycystic ovaries are also
found in women with type A insulin resistance resulting from
a mutation of the IR. Women with extreme insulin resistance
due to mutations in the IR exhibit severe hyperandrogenism
and hyperinsulinism, similar to women with PCOS. These
women have normal to low gonadotropins (Musso et al., 2005;
Vambergue et al., 2006), in contrast to women with PCOS, impli-
cating direct insulin signaling on the ovary contributing to the
ovarian dysfunction. It is tempting to speculate that women
with IR mutations are similar to our PitIRKO model, with normal
LH levels in the setting of hyperinsulinemia and less robust
response to GnRH stimulation than hyperinsulinemic controls.
In contrast to our model, these women also lack insulin signaling
in the brain and hypothalamus, which has been shown to regu-
late GnRH production using a brain-specific IR KOmousemodel
(Bru¨ning et al., 2000) and may contribute to the decrease in
observed LH levels in these women. The degree of hyperandro-
genemia is also higher in these women compared to our mouse
model, which may be due to differences in central regulation of
the reproductive axis.
A recent report by Nandi et al. demonstrated that insulin resis-
tance in the absence of hyperglycemia did not result in elevated
testosterone levels or drastic ovarian dysfunction in mice (Nandi
et al., 2010). This paper further supports a model in which
elevated insulin signaling in the pituitary, rather than insulin resis-
tance, contributes to infertility.
Strain differences associatedwith DIO and infertility have been
debated following the results of Tortoriello et al. (2004), who
showed that one strain of DBA/2J mice became infertile afterCell Meconsuming a 35% fat by weight diet, while another strain of
C57BL/6J mice displayed normal fertility. The C57BL/6J mice
also gained significantly less weight than the DBA/2J mice, dis-
playing resistance to theHFD.Our studies involvedamixedback-
ground strain of CD1/129SvJ/C57BL6mice, which suggests that
our resultsmay reflect a fundamental property of dysregulation of
reproductive function in obesity rather than strain-specific differ-
ences. While the mixed background model that we used may
more closely resemble the DBA/2J mice described above, it is
difficult to assess whether the higher-percent-fat chow we used
(65%) would more generally induce obesity and infertility than
the 35% used by Tortoriello et al. (2004).
In summary, these findings indicate a direct role for insulin
signaling in the gonadotroph that is revealed in an obesity model
of infertility. When WT mice became obese, they showed meta-
bolic and reproductive profiles similar to women with hyperinsu-
linemia and fertility deficiencies such as PCOS. When the IR was
ablated in the gonadotroph, obese PitIRKO mice displayed an
improvement in reproductive function, implicating pituitary
insulin signaling in the genesis of obesity-induced infertility.
EXPERIMENTAL PROCEDURES
Animals
Floxed-IRmicewere designedwith loxP sites flanking exon 4 of the IR as previ-
ously described (Bru¨ning et al., 2000). The aGSU transgenic mice have been
previously described by our lab (Naik et al., 2006; Singh et al., 2009). All of
the mice used in these experiments were maintained on a mixed CD1/
129SvJ/C57BL6 genetic background, and each genotypic or dietary experi-
mental group was compared to littermate controls carrying the floxed IR
genewithout the aCre, carrying the aCrewithout the floxed IR gene, or carrying
neither aCre nor floxed IR. These littermate controls are referred to asWTmice
throughout this manuscript. All procedures were performed with approval of
the Johns Hopkins Animal Care and Use Committee under standard light
and dark cycles. Prior to all experiments, mice were anesthetized with isoflur-
ane (Penn Veterinary Supply; Lancaster, PA), and blood samples were ob-
tained via mandibular bleed or ocular bleed in the case of terminal studies.
Generation of PitIRKO
Floxed-IR mice were crossed with aGSU Cre mice in order to create PitIRKO.
Genotyping primers for the presence of the floxed allele were as follows: P1,
50-TGCACCCCATGTCTGGGACCC-30; P2, 50-GCCTCCTGAATAGCTGAGA
CC-30. Genotyping primers used to determine the presence of the Cre recom-
binase gene were CreF, 50-ACGACCAAGTGACAGCAATGCTGT-30; CreR,
50CGGTGCTAACCAGCGTTTTCGTTC-30. The KO allele was visualized via
PCR reaction including three primers: P1, P2, and P3: 50-TCTATCATGTGAT
CAATGATTC-30 according to the strategy described by Kulkarni et al.
(1999). Primers P1 and P2were designed to produce a 320 bp band to indicate
the floxed-IR alleles in tissue DNA samples taken from liver, muscle, hypothal-
amus, ovary, and pituitary. Primers P2 and P3 were designed to produce
a 220 bp band following excision of the sequence between the loxP sites.
Generation of DIO
Mice were placed on a HFD starting at 8 weeks of age and maintained on the
diet for 12 weeks prior to study and throughout the course of study. The HFD
consisted of 20% kcal from protein, 20% kcal from carbohydrate, and
60% kcal from fat with an energy density of 5.24 kcal/gm (Research Diets,
Inc.; New Brunswick, NJ). Wood chip bedding was maintained in these cages
so that mice would not supplement their diet by eating the standard corncob
bedding. Mice were weighed every 2 weeks along with a lean cohort of control
littermates maintained on a regular chow diet. The regular chow diet (Tekland
Global 18% protein diet) was 24% kcal from protein, 58% kcal from carbohy-
drate, and 18% kcal from fat with an energy density of 3.1 kcal/g (Harlan Labo-
ratories; Indianapolis, IN).tabolism 12, 295–305, September 8, 2010 ª2010 Elsevier Inc. 303
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and leptin levels. Glucose wasmeasured using a Glucometer Elite glucometer,
while serum insulin and leptin were measured on the Luminex 200IS system
using the Milliplex Map Mouse Serum Adipokine Panel (Millipore; Billerica,
MA) (see Hormone Assays below).
Estrous Cycle Analysis
Vaginal cytology was assessed daily between 9:00 and 10:00 a.m. for 10
consecutive days and then analyzed for percent time spent in each stage.
Vaginal cells were collected via saline lavage and then fixed with methanol
and stained with the DIFF Quick Stain Kit (IMEB Inc.; San Marcos, CA). Stages
were assessed based on vaginal cytology (Nelson et al., 1982): predominant
cornified epithelium indicated the estrus stage, predominant nucleated cells
indicated the proestrus stage, both cornified and leukocytes indicated the
metestrus stage, and predominant leukocytes indicated the diestrus stage.
Hormone Assays
To measure serum levels of LH, FSH, insulin, and leptin, serum samples were
collected from mice via mandibular bleed. Serum samples were obtained
between 9:00 and 10:00 a.m. so as to avoid cycle-dependent LH surges
occurring in late afternoon on the evening of proestrus. Rodent morning LH
levels are not thought to vary in a cycle-dependent manner (Helena et al.,
2006). For fasting measurements of insulin, leptin, and glucose, samples
were also obtained between 9:00 and 10:00 a.m. Serum was analyzed on
a Luminex 200IS platform using the Milliplex Map Rat Pituitary Panel. Serum
samples from individual mice were analyzed in duplicate. A standard curve
was generated using 5-fold serial dilutions of the hormone reference provided
by Millipore. Low- and high-quality controls were also run on each assay to
assess CV values. The assay detection limit for LH was 0.048 ng/ml; for
FSH, 0.032 ng/ml; for insulin, 18.5 pM; and for leptin, 6.2 pM. Serum testos-
terone was measured by radioimmunoassay at the University of Virginia
Ligand Assay Core.
GnRH Stimulation
Blood was collected from mice via mandibular bleed prior to subcutaneous
injection of 100 ng/kg GnRH (Sigma L7134 LH releasing hormone human
acetate salt). Ten minutes after injection, blood was collected again from the
other cheek. Fold change in serum LH was assessed.
Quantitative Real-Time PCR
Total RNA was extracted from pituitary tissue using TRIzol reagent (Invitrogen;
San Diego, CA) according to the manufacturer’s protocol. RNA was reverse
transcribed using the iScript cDNA synthesis kit (BioRad; Hercules, CA).
PCR reactions were performed with IQ SYBR Green Supermix (BioRad), and
fluorescence was measured using the MyiQ quantitative real-time thermocy-
cler (BioRad). The following primer sets were used: LHb (sense 50-CAGTCTG
CATCACCTTCACCA-30 and antisense 50-GGTAGGTGCACACTGGCTGA-30),
aGSU (sense 50-GTGTATGGGCTGTTGCTTCTCC-30 and antisense 50-GCA
CTCCGTATGATTCTCCACTCTG-30), GnRH-R (sense 50-CAGCTTTCATGAT
GGTGGTG-30 and antisense 50-TAGCGAATGCGACTGTCATC-30 ), GAPDH
(sense 50-GGGCATCTTGGGCTACACT-30 and antisense 50-GGCATCGAA
GGTGGAAGAGT-30), and ribosomal 18S (sense 50-GCATGGCCGTTCTTAG
TTGG-30 and antisense 50-TGCCAGAGTCTCGTTCGTTA-30 ). Each reaction
was run in triplicate, and for each assay a standard curve was created using
10-fold serial dilutions of cDNA. All experiments had efficiencies between
95% and 105% and displayed normal melt curves. Fold changes in relative
gene expression were calculated by 2D(DCt), where DCt = Ct (gene of
interest)  Ct (18S) and D(DCt) = DCt (PitIRKO, WT DIO, or PitIRKO DIO
gene of interest)mean DCt (WT lean gene of interest). Results are expressed
as fold differences in relative gene expression with respect to WT lean.
Ovarian Histology
Ovaries were collected from mice and placed immediately in 10% formalin.
Sections of ovarian tissue (5 mm) were obtained every 100 mm throughout
the length of the ovary. Ovaries were stained with H&E by the Johns Hopkins
Molecular and Comparative Pathobiology Phenotyping Core. The total
number of corpora lutea counted per mouse was compared across groups.304 Cell Metabolism 12, 295–305, September 8, 2010 ª2010 ElsevieBreeding Studies
Female mice were entered into a breeding rotation with four proven-fertile WT
lean males. Each female spent 7 days in a cage with a male and then was
removed for 28 days to allow for determination of pregnancy. Pregnancy
was assessed by the generation of litters during that 28 day period. Once
the 28 days were up, that female was moved into a cage with the next male.
This way, each female was rotated through all four males, and had the same
amount of time (7 days) in which to attempt pregnancy. Vaginal plugs were
usually observed in obese animals, indicating that the infertility was unlikely
to be due to a mechanical defect.
Based on the number of successful pregnancies resulting from the four
mating attempts, a fertility rate was calculated for each individual female.
The mating success rates were then compared across groups.
Insulin Stimulation
Blood was collected from mice via mandibular bleed prior to subcutaneous
injection of 1.5 U/kg regular insulin (Lilly; Indianapolis, IN) and 40 min following
injection. An injection of 20% glucose weight/volumewas also administered at
the same time as the insulin, and glucose levels weremonitored throughout the
experiment to confirm that the glucose administration was sufficient to prevent
the mice from becoming hypoglycemic.
Insulin Signaling Assay
WT lean, WT DIO, PitIRKO lean, and PitIRKO DIO mice were fasted overnight
and injected intraperitoneally with 1.5 U/kg body weight insulin or 0.9% saline.
Mice were sacrificed after 10 min for pituitary, liver, and muscle tissue collec-
tion. Tissues were snap frozen in liquid nitrogen and then homogenized in 13
Cell Lysis Buffer (Cell Signaling Technology; Danvers, MA) supplemented with
Complete Protease Inhibitor Cocktail Tablets (Roche Diagnostics; Indianapo-
lis, IN) and PhosSTOP Phosphatase Inhibitor Cocktail Tablets (Roche Diag-
nostics). Protein concentration was quantified by BCA Protein Assay (Pierce
Chemical Co.; Rockford, IL). To quantify levels of phospho-Akt/PKB
(Ser473), 10 mg protein from each tissue was analyzed with the Cell Signaling
Buffer and Detection Milliplex Map Kit with assay buffer 2 (Millipore) according
to the manufacturer’s protocol using the Luminex200 (Austin, TX) system.
Analysis was performed using the XPonent 3.0 software program. Total MEK
was also measured in the same well as an internal loading control. Values
were assessed as mean fluorescent intensity (MFI) of phospho-specific signal.
Statistical Analysis
All results are expressed as mean ±SEM. Significance was determined via
one- or two-way ANOVA with the appropriate post hoc tests if significant vari-
ations were observed across groups. The graphs and analyses were con-
structed using the GraphPad Prism 4 program (La Jolla, CA).
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